Drug
Lactulose Crystals
Lactulose Crystals: highest development phase Post-Market, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lactulose crystals 20 g NCT03666546 | Post-Market | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Lactulose Crystals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.